FDA Adverse Event Malfunction Summary report: N

NUC 4 OS IMG IOT10/EPI 4.0

MDR report key: 16773343 · Received April 19, 2023

Report

Report Number
1119779-2023-00448
Event Type
Malfunction
Date Received
April 19, 2023
Date of Event
March 21, 2023
Report Date
June 1, 2023
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
JQP
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H.3. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED. THE ISSUE BEING REPORTED IS WITH THE EPICENTER SOFTWARE WHICH IS LOADED IN THE NUC PLEASE SEE BELOW FOR EPICENTER SOFTWARE 510K INFORMATION BEING USED: D1: MEDICAL DEVICE BRAND NAME: BD EPICENTER¿ SINGLE USER SOFTWARE. D2A: COMMON DEVICE NAME: CALCULATOR/DATA PROCESSING MODULE. D2B: MEDICAL DEVICE TYPE OR (PROCODE):JQP. D4 MEDICAL DEVICE CATALOG #: 444165. G5. PMA/510K INFO: EXEMPT.

Additional Manufacturer Narrative · 0

H.6 INVESTIGATION SUMMARY: CUSTOMER REPORTED THAT AFTER EPI UPGRADE TO V 7.21Q (444162/SN (B)(6) SYNERCID WAS NOT BLOCKED/SUPPRESSED AS THE DISCONTINUATION CUSTOMER LETTER STATED AND CUSTOMER DID IT MANUALLY. UPON FURTHER INVESTIGATION, THE PANELS USED CONTAINED SYNERCID AND THE RESULTS ON THOSE LOTS OF PANELS SHOULD HAVE BEEN REPORTED AS EXPECTED. THIS IS NOT A CONFIRMED COMPLAINT OF A BD PRODUCT. COMPLAINTS FOR SOFTWARE WERE UNDER STATISTICAL CONTROL FOR THE MONTH OF MARCH. NO TRENDS INDICATED. DEVICE HISTORY RECORD REVIEW IS NOT REQUIRED FOR STANDALONE SOFTWARE. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD EPICENTER¿ SINGLE USER SOFTWARE UPGRADE WAS NOT BLOCKED AND SYNERCID IS NOT MEANT TO PROVIDE RESULT BUT IT DID. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: REPORTED THAT AFTER EPI UPGRADE TO V 7.21Q SYNERCID WAS NOT BLOCKED/SUPPRESSED AS THE DISCONTINUATION CUSTOMER LETTER STATED AND CUSTOMER DID IT MANUALLY. 1- D-TEST FAILED AND TRANSFERRED CLINDA AS SENSITIVE, GENTAMYCIN, MOXIFLOXACIN AND TETRACYCLINE SHOULD¿VE NOT CROSS TO LIS. 2-GENTAMYCIN AND MOXIFLOXACIN SHOULD¿VE NOT CROSS TO LIS.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD EPICENTER¿ SINGLE USER SOFTWARE UPGRADE WAS NOT BLOCKED AND SYNERCID IS NOT MEANT TO PROVIDE RESULT BUT IT DID. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: REPORTED THAT AFTER EPI UPGRADE TO V 7.21Q SYNERCID WAS NOT BLOCKED/SUPPRESSED AS THE DISCONTINUATION CUSTOMER LETTER STATED AND CUSTOMER DID IT MANUALLY 1- D-TEST FAILED AND TRANSFERRED CLINDA AS SENSITIVE, GENTAMYCIN, MOXIFLOXACIN AND TETRACYCLINE SHOULD¿VE NOT CROSS TO LIS. 2-GENTAMYCIN AND MOXIFLOXACIN SHOULD¿VE NOT CROSS TO LIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1601442 NUC 4 OS IMG IOT10/EPI 4.0 CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE JQP BECTON, DICKINSON & CO. (SPARKS)

Patients

Seq Age Sex Outcome Treatment
1 Unknown